BioNTech Appoints New CFO
Ticker: BNTX · Form: 6-K · Filed: May 5, 2025 · CIK: 1776985
| Field | Detail |
|---|---|
| Company | Biontech Se (BNTX) |
| Form Type | 6-K |
| Filed Date | May 5, 2025 |
| Risk Level | low |
| Sentiment | neutral |
Sentiment: neutral
Topics: management-change, cfo-appointment
Related Tickers: BNTX
TL;DR
BioNTech SE names Ramó n Zapata-Gomez as new CFO, effective May 5, 2025.
AI Summary
On May 5, 2025, BioNTech SE announced the appointment of Ramó n Zapata-Gomez to its Management Board as Chief Financial Officer, effective immediately. This appointment was made by the Supervisory Board.
Why It Matters
The appointment of a new Chief Financial Officer is a significant leadership change that can impact the company's financial strategy and investor confidence.
Risk Assessment
Risk Level: low — This filing is a routine leadership announcement with no immediate financial implications.
Key Players & Entities
- BioNTech SE (company) — Registrant
- Ramó n Zapata-Gomez (person) — Appointed Chief Financial Officer
- May 5, 2025 (date) — Effective date of appointment
FAQ
Who has been appointed as the new Chief Financial Officer of BioNTech SE?
Ramó n Zapata-Gomez has been appointed as the new Chief Financial Officer of BioNTech SE.
When is the appointment of Ramó n Zapata-Gomez effective?
The appointment of Ramó n Zapata-Gomez is effective as of May 5, 2025.
Who made the decision to appoint Ramó n Zapata-Gomez?
The Supervisory Board of BioNTech SE appointed Ramó n Zapata-Gomez.
What is the role Ramó n Zapata-Gomez will assume?
Ramó n Zapata-Gomez will assume the role of Chief Financial Officer on the Management Board.
What is the filing type and date?
This is a Form 6-K filed on May 5, 2025.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 5, 2025 by Ramó n Zapata-Gomez regarding BioNTech SE (BNTX).